Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus

Oct.26.2022
Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus
Advocates call for ban on flavored tobacco products in Columbus stores to address marketing targeting vulnerable communities.

Health advocates are urging the Columbus City Council to ban the sale of menthol cigarettes and flavored electronic cigarettes in stores throughout the city.


Amanda Turner, the Executive Director of Tobacco 21, stated that the city council has not yet proposed any legislation, but the proposal is currently being drafted. Turner explained that this issue first arose approximately 18 months ago during a conversation with the Columbus Department of Public Health.


Dr. Phillip Gardner, a public health expert, has stated that 85 cities in the United States have already banned the sale of menthol cigarettes and flavored e-cigarettes, with an additional 300 cities recently banning the sale of flavored e-cigarettes. Gardner, who is co-chair of the African American Tobacco Control Leadership Council, also noted that Canada has a nationwide ban on the sale of menthol cigarettes.


Gardner and Turner stated that prohibiting the sale of these products in the city will begin to reverse the effects of decades of marketing aimed specifically at black people, other people of color, women, LGBTQ individuals, and other marginalized groups. Gardner said that the industry profits by using "disproportionate marketing and predatory plunder" to exploit vulnerable communities and make a profit.


According to him, tobacco marketers have discovered that promoting menthol cigarettes to black celebrities and athletes, even lowering their costs in communities with African Americans. Currently, 85% of black smokers use menthol cigarettes, while the same figure for white smokers is 30%. "In the early 1950s, only 5% of African Americans smoked menthol cigarettes. By 1968, this percentage had almost tripled to 14%. By 1976, it had tripled again to 42%," Gardner said.


He stated that despite critics suggesting that such a ban would only create an illegal market or push shoppers to other jurisdictions, the data indicates that this has not been the case in these areas. Turner further explained that the data shows that removing more addictive tobacco from the equation would aid individuals in quitting smoking.


Many individuals may switch products, but research indicates that if you are using menthol cigarettes and wish to quit smoking and switch to regular cigarettes, your chances of successfully quitting are higher because menthol is a flavoring. It is a cooling agent that can suppress coughing, Turner explained.


Gardner stated that this is "outrageous" because adding menthol makes people more susceptible to nicotine addiction and more difficult to quit. "Menthol is defined as an anesthetic that actually covers up the harsh taste of tobacco smoke. It has a numbing and cooling effect and allows for deeper inhalation. The deeper you inhale, the more toxins and nicotine you ingest," Gardner said. "The more nicotine and toxins you ingest, the more addicted you become. Quitting becomes even harder. That's why they put it in there. It's outrageous from the start.


Gardiner stated that the FDA is currently exploring the idea of banning the use of menthol in cigarettes, but the process would take too long. "The FDA is considering getting rid of menthol, but unfortunately, due to the FDA's delay, it is important for communities like Columbus to take action themselves. The FDA will need several years to accomplish this," he said.


Turner and Gardner stated that the ban would not prohibit products within the city, but only the sale of them. Therefore, individuals would not face trouble for purchasing and bringing them in from elsewhere. "These laws are about getting retailers to stop selling them and not about individuals using personal property or pursuing a percentage," said Gardner.


Critics say the ban is unfair to smokers who enjoy menthol or use flavored e-cigarettes as an alternative to traditional cigarettes. Some argue that it discriminates against Black smokers. In response, Gardner stated that "racists are not public health doctors, they're in the tobacco industry." "Indeed, it has been the tobacco industry that has been discriminatory, that has been racist," Gardner continued. "It is not the tobacco control movement that is trying to save lives.


When asked why health officials are taking action to prevent flavored tobacco instead of flavored alcohol, Gardner explained that occasional alcohol consumption, not including binge drinking, does not kill people. However, "if you use cigarettes as expected, 50% of people will die from smoking.


Cigarettes are more deadly. In fact, tobacco-related diseases are the leading cause of death in the world, including in the United States, Ohio, and unfortunately Columbus. This is the reality. We are working hard to save lives," Gardner said.


Art Way, a drug policy consultant who works with the tobacco industry, argues that focusing on smoking cessation is a more effective way to reduce nicotine addiction. Targeted bans like these, Way contends, are similar to "patronizing, drug war-type policies that do not benefit our communities.


Statement:


This article is based on compiled third-party information and is only intended for intra-industry communication and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is solely for industry research and communication purposes.


Due to limitations in translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan or foreign-related expressions and perspectives.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
Australia's Illicit Tobacco Market May Have Turned After Five Years of Growth, With Estimates Showing Up to 25% Decline Amid Tax-Cut Debate
Australia's Illicit Tobacco Market May Have Turned After Five Years of Growth, With Estimates Showing Up to 25% Decline Amid Tax-Cut Debate
New Australian government estimates released on November 15, 2026, suggest that the country's illicit tobacco market may have contracted for the first time following five years of growth. Estimated market volume fell from a previous peak of 5,972 tonnes to a range of 4,453–5,893 tonnes. The government attributed the change to stronger border enforcement and coordinated domestic operations. Australian Border Force seized more than 2,300 tonnes of illicit tobacco and 13.2 million illicit vaping products in 2025–26, followed by approximately 730 tonnes of illicit tobacco in the first quarter of 2026–27. Separate experimental estimates from the Australian Bureau of Statistics indicate that illicit sources accounted for approximately 80% of nicotine consumption in 2025.
Regulations
Nov.16
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives
Product | PMI Launches Three IQOS ILUMA i BEYOND Limited Editions in Japan, Retaining REMIX Pricing and Retail Channel Structure
Product | PMI Launches Three IQOS ILUMA i BEYOND Limited Editions in Japan, Retaining REMIX Pricing and Retail Channel Structure
Philip Morris Japan (PMJ) began launching three IQOS ILUMA i BEYOND limited-edition heated tobacco devices in Japan on November 18, 2026, covering PRIME, the standard ILUMA i and ONE. Suggested retail prices are ¥11,980, ¥7,980 and ¥4,980, respectively, matching the REMIX limited-edition collection introduced in June. BEYOND features blue finishes, translucent components and differentiated surface materials while retaining the existing IQOS ILUMA i device architecture. As with REMIX, all three models are available through official and specialist retail channels, while the subsequent convenience store rollout covers only the standard ILUMA i and ONE versions. The two collections share the same pricing tiers and retail distribution structure, with their principal differences in exterior design.
product
Nov.20